222 related articles for article (PubMed ID: 8093870)
21. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
22. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis.
Collen MJ; Loebenberg MJ
Dig Dis Sci; 1989 Feb; 34(2):246-50. PubMed ID: 2914546
[TBL] [Abstract][Full Text] [Related]
23. Gastric acid study in patients operated on for perforated duodenal ulcer.
Lala AK; Rai PC; Ramachandran K; Jain S; Chaudhury R
Indian J Gastroenterol; 1994 Oct; 13(4):135-6. PubMed ID: 7829143
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
25. Do non-steroidal anti-inflammatory drugs cause duodenal ulcer? Evaluation of basal acid output and ulcer complications.
Collen MJ; Abdulian JD
J Gastroenterol Hepatol; 1996 Jun; 11(6):520-3. PubMed ID: 8792303
[TBL] [Abstract][Full Text] [Related]
26. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection.
Capurso G; Annibale B; Osborn J; D'Ambra G; Martino G; Lahner E; Delle Fave G
Aliment Pharmacol Ther; 2001 Jun; 15(6):821-9. PubMed ID: 11380320
[TBL] [Abstract][Full Text] [Related]
27. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
[TBL] [Abstract][Full Text] [Related]
28. Medical therapy of peptic ulcer disease.
McQuaid KR; Isenberg JI
Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
[TBL] [Abstract][Full Text] [Related]
29. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
Forssell H; Koch G
Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
[TBL] [Abstract][Full Text] [Related]
30. Previous use of non-steroidal anti-inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers.
Vreeburg EM; de Bruijne HW; Snel P; Bartelsman JW; Rauws EA; Tytgat GN
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):41-4. PubMed ID: 9031897
[TBL] [Abstract][Full Text] [Related]
31. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
Jensen DM; Cheng S; Kovacs TO; Randall G; Jensen ME; Reedy T; Frankl H; Machicado G; Smith J; Silpa M
N Engl J Med; 1994 Feb; 330(6):382-6. PubMed ID: 8284002
[TBL] [Abstract][Full Text] [Related]
32. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
33. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
[TBL] [Abstract][Full Text] [Related]
34. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
35. Age-related mortality in patients treated endoscopically for bleeding peptic ulcer.
Choudari CP; Elton RA; Palmer KR
Gastrointest Endosc; 1995 Jun; 41(6):557-60. PubMed ID: 7672548
[TBL] [Abstract][Full Text] [Related]
36. Bleeding gastric and duodenal ulcers: endoscopic therapy versus surgery.
Ralph-Edwards A; Himal HS
Can J Surg; 1992 Apr; 35(2):177-81. PubMed ID: 1562929
[TBL] [Abstract][Full Text] [Related]
37. [Incidence and risk factors of rebleeding from gastric and duodenal ulcers].
Winiarski M; Biesiada Z; Rembiasz K; Bolt L; Guzik P; Zasada J
Przegl Lek; 2003; 60 Suppl 7():7-12. PubMed ID: 14679685
[TBL] [Abstract][Full Text] [Related]
38. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
Mahachai V; Walker K; Pinchbeck B; Thomson AB
Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
Hirschowitz BI; Mohnen J; Shaw S
Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
[TBL] [Abstract][Full Text] [Related]
40. Different implications of stigmata of recent hemorrhage in gastric and duodenal ulcers.
Chang-Chien CS; Wu CS; Chen PC; Lin DY; Chu CM; Fang KM; Sheen IS; Liaw YF
Dig Dis Sci; 1988 Apr; 33(4):400-4. PubMed ID: 3349885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
